BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND SDHC, CYBL, 6391, ENSG00000143252, SDH3, PGL3, QPS1, CYB560 AND Treatment
7 results:

  • 1. Alternative Promoters of
    Zhawar VK; Kandpal RP; Athwal RS
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328043
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
    Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
    Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Stereotactic radiosurgery to surgical cavity post resection of brain metastases: Local recurrence and overall survival rates. A single-centre experience.
    Higgins MJ; Burke O; Fitzpatrick D; Nugent KG; Skourou C; Dunne M; Javadpour M; Faul C
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):726-733. PubMed ID: 30044047
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
    Omuro A; Correa DD; DeAngelis LM; Moskowitz CH; Matasar MJ; Kaley TJ; Gavrilovic IT; Nolan C; Pentsova E; Grommes CC; Panageas KS; Baser RE; Faivre G; Abrey LE; Sauter CS
    Blood; 2015 Feb; 125(9):1403-10. PubMed ID: 25568347
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hyperacetylation of histone H3K9 involved in the promotion of abnormally high transcription of the gdnf gene in glioma cells.
    Yu ZQ; Zhang BL; Ni HB; Liu ZH; Wang JC; Ren QX; Mo JB; Xiong Y; Yao RQ; Gao DS
    Mol Neurobiol; 2014 Dec; 50(3):914-22. PubMed ID: 24619502
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Connecting molecular pathways to hereditary cancer risk syndromes.
    Testa JR; Malkin D; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. treatment by a specialist surgical neuro-oncologist does not provide any survival advantage for patients with a malignant glioma.
    Latif AZ; Signorini DF; Whittle IR
    Br J Neurosurg; 1998 Feb; 12(1):29-32. PubMed ID: 11013644
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.